Tampucci, S.; Carpi, S.; Digiacomo, M.; Polini, B.; Fogli, S.; Burgalassi, S.; Macchia, M.; Nieri, P.; Manera, C.; Monti, D.
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma. Molecules 2019, 24, 1793.
https://doi.org/10.3390/molecules24091793
AMA Style
Tampucci S, Carpi S, Digiacomo M, Polini B, Fogli S, Burgalassi S, Macchia M, Nieri P, Manera C, Monti D.
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma. Molecules. 2019; 24(9):1793.
https://doi.org/10.3390/molecules24091793
Chicago/Turabian Style
Tampucci, Silvia, Sara Carpi, Maria Digiacomo, Beatrice Polini, Stefano Fogli, Susi Burgalassi, Marco Macchia, Paola Nieri, Clementina Manera, and Daniela Monti.
2019. "Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma" Molecules 24, no. 9: 1793.
https://doi.org/10.3390/molecules24091793
APA Style
Tampucci, S., Carpi, S., Digiacomo, M., Polini, B., Fogli, S., Burgalassi, S., Macchia, M., Nieri, P., Manera, C., & Monti, D.
(2019). Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma. Molecules, 24(9), 1793.
https://doi.org/10.3390/molecules24091793